|
Sign In to gain access to subscriptions and/or personal tools.
|
Spotlight on ReninCardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system
Jose A Garcia-Donaire
Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain
Luis M Ruilope
Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain
References
- Segura J., Ruilope LM, Zanchetti A. On the importance of estimating renal function for cardiovascular risk assessment. J Hypertens 2004;22:1635-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ruilope LM The kidney as a sensor of cardiovascular risk in essential hypertension. J Am Soc Nephrol 2002;13(suppl 3):S165-S168.[Abstract/Free Full Text]
- Swedko PJ, Clark HD, Paramsothy K., Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003;163:356-60.[Abstract/Free Full Text]
- Cockroft DW, Gault MH Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.[Web of Science][Medline]
[Order article via Infotrieve]
- Levey AS, Bosch J., Lewis JB, Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.[Abstract/Free Full Text]
- National Kidney Foundation: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(suppl 1):S1-S266.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ruilope LM, Salvetti A., Jamerson K. et al. Renal function and intensive lowering of blood pressure in the hypertensive subjects of the HypertensionOptimal Treatment (HOT) study. J Am Soc Nephrol 2001;12:218-25.[Abstract/Free Full Text]
- Henry RMA, Kostense PJ, Bos G. et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 2002;62:1402-07.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hillege HL, Fidler V., Diercks GF et al. Urinary albumin excretion predicts cardiovascular and non cardiovascular mortality in general population. Circulation 2002; 106:1777-82.[Abstract/Free Full Text]
- Wachtell K., Olsen MH, Dahlof B. et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002;20:405-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Manjunath G., Tighiouart H., Ibrahim H. et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community. J Am Coll Cardiol 2003;41:47-55.[Abstract/Free Full Text]
- Sowers JR, Haffner S. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension 2002;40:781-8.[Free Full Text]
- Morrisey K., Evans RA, Wakefield L., Phillips AO Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin. Am J Pathol 2001:159:1905-15.[Abstract/Free Full Text]
- Rerolle JP, Hertig A., Nguyen G., Sraer JD, Rondeau EP Plasminogen activator inhibitor type 1 is a potential target in renal fibrinogenesis. Kidney Int 2000;58:1841-50.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hodge AM, Dowse GK, Zimmet PZ Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996;13:441-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
- Chobanian A., Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003;289:2560-72.[Abstract/Free Full Text]
- Segura J., Campo C., Ruilope LM Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int 2004;6(suppl 92):S1-S5.
- Segura J., Campo C., Rodicio JL, Ruilope LM ACE inhibitors and appearance of renal events in hypertensive patients. Hypertension 2001;38:645-49.[Abstract/Free Full Text]
- Tonelli M., Isles C., Curhan GC, Tonkin A., Pfeffer MA, Shepherd J., et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 2004;110:1557-63.[Abstract/Free Full Text]
- Grothusen C., Bley S., Selle T. et al. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis. Atherosclerosis 2005;182(1):57-69.[Web of Science][Medline]
[Order article via Infotrieve]
- Curtis BM, Levin A., Parfrey PS Multiple risk factor intervention in chronic kidney disease: management of cardiac disease in chronic kidney disease patients. Med Clin North Am 2005;89:511-23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 1,
56-58 (2006)
DOI: 10.3317/jraas.2006.007

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|